Administrative data and scientific evidence: a lesson from France - the safety of systemic treatment for psoriasis during the COVID-19 pandemic.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 34726776.
- Also identified by DOI 10.1111/bjd.20776 and PMC identifier 8652619.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
<b>Linked Article:</b> Penso <i>et al</i>. <i>Br J Dermatol</i> 2022; <b>186</b>:59–68.
Medical subject headings
- COVID-19
- Psoriasis